Mereo BioPharma (UK) Price Prediction
| 0A9G Stock | 3.72 0.10 2.76% |
Oversold Vs Overbought
51
Oversold | Overbought |
Wall Street Target Price 4.38 |
Using Mereo BioPharma hype-based prediction, you can estimate the value of Mereo BioPharma Group from the perspective of Mereo BioPharma response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Mereo BioPharma to buy its stock at a price that has no basis in reality. In that case, they are not buying Mereo because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Mereo BioPharma after-hype prediction price | USD 3.73 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mereo |
Mereo BioPharma After-Hype Price Prediction Density Analysis
As far as predicting the price of Mereo BioPharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mereo BioPharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mereo BioPharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mereo BioPharma Estimiated After-Hype Price Volatility
In the context of predicting Mereo BioPharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mereo BioPharma's historical news coverage. Mereo BioPharma's after-hype downside and upside margins for the prediction period are 0.19 and 7.46, respectively. We have considered Mereo BioPharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mereo BioPharma is unstable at this time. Analysis and calculation of next after-hype price of Mereo BioPharma Group is based on 3 months time horizon.
Mereo BioPharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Mereo BioPharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mereo BioPharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mereo BioPharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.32 | 3.73 | 0.01 | 3.19 | 3 Events / Month | 2 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
3.72 | 3.73 | 0.27 |
|
Mereo BioPharma Hype Timeline
Mereo BioPharma Group is presently traded for 3.72on London Exchange of UK. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -3.19. Mereo is projected to increase in value after the next headline, with the price projected to jump to 3.73 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is projected to be 0.27%, whereas the daily expected return is presently at -0.32%. The volatility of related hype on Mereo BioPharma is about 37.38%, with the expected price after the next announcement by competition of 0.53. The company reported the revenue of 1000 K. Net Loss for the year was (34.2 M) with profit before overhead, payroll, taxes, and interest of 936 K. Assuming the 90 days trading horizon the next projected press release will be in about 3 days. Check out Mereo BioPharma Basic Forecasting Models to cross-verify your projections.Mereo BioPharma Related Hype Analysis
Having access to credible news sources related to Mereo BioPharma's direct competition is more important than ever and may enhance your ability to predict Mereo BioPharma's future price movements. Getting to know how Mereo BioPharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mereo BioPharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SMSD | Samsung Electronics Co | 7.00 | 1 per month | 0.00 | (0.27) | 2.72 | (3.78) | 10.21 | |
| SMSN | Samsung Electronics Co | (2.00) | 2 per month | 0.00 | (0.29) | 3.19 | (4.02) | 13.39 | |
| HYUD | Hyundai Motor | (0.60) | 2 per month | 0.00 | (0.1) | 4.76 | (3.64) | 12.58 | |
| TYT | Toyota Motor Corp | (37.50) | 3 per month | 2.14 | (0.04) | 3.04 | (3.19) | 12.68 | |
| 0RUK | MOL Hungarian Oil | 0.00 | 0 per month | 0.00 | (0) | 0.00 | 0.00 | 17.70 | |
| RIGD | Reliance Industries Ltd | 0.1 | 4 per month | 0.00 | (0.26) | 2.47 | (2.70) | 7.89 | |
| 0R15 | SoftBank Group Corp | (56.86) | 3 per month | 0.00 | (0.13) | 5.19 | (6.96) | 15.31 | |
| HHPD | Hon Hai Precision | (0.04) | 2 per month | 1.76 | 0.02 | 3.14 | (3.02) | 8.38 | |
| SBID | State Bank of | 0.1 | 3 per month | 0.00 | (0.09) | 2.23 | (2.41) | 8.15 |
Mereo BioPharma Additional Predictive Modules
Most predictive techniques to examine Mereo price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mereo using various technical indicators. When you analyze Mereo charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Mereo BioPharma Predictive Indicators
The successful prediction of Mereo BioPharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mereo BioPharma Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mereo BioPharma based on analysis of Mereo BioPharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mereo BioPharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mereo BioPharma's related companies.
Story Coverage note for Mereo BioPharma
The number of cover stories for Mereo BioPharma depends on current market conditions and Mereo BioPharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mereo BioPharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mereo BioPharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Mereo Stock Analysis
When running Mereo BioPharma's price analysis, check to measure Mereo BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mereo BioPharma is operating at the current time. Most of Mereo BioPharma's value examination focuses on studying past and present price action to predict the probability of Mereo BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mereo BioPharma's price. Additionally, you may evaluate how the addition of Mereo BioPharma to your portfolios can decrease your overall portfolio volatility.